However, the role of PDLIM1 in pancreatic cancer still needs further research, which may help to explore the potential of PDLIM1 as an early diagnostic marker or drug target for pancreatic cancer. This evidence concerns the gene PDLIM1 and familial pancreatic carcinoma.